As of 2025-05-17, the Relative Valuation of Covetrus Inc (CVET) is 0.35 USD. This relative valuation is based on P/E multiples. With the latest stock price at 20.99 USD, the upside of Covetrus Inc based on Relative Valuation is -98.3%.

The range of the Relative Valuation is (1.92) - 2.78 USD.

Note: valuation result may not be accurate due to the company's negative earnings.

	Range	Selected
Trailing P/E multiples	20.7x - 21.6x	21.3x
Forward P/E multiples	17.8x - 22.4x	21.6x
Fair Price	(1.92) - 2.78	0.35
Upside	-109.2% - -86.7%	-98.3%

20.99 USD

Stock Price

0.35 USD

Fair Price

Relative Valuation

CVET Relative Valuation - Benchmarking P/E against peers

(USD in millions except Fair Price)
	Market Cap (USD mil)	Trailing P/E	Forward P/E
Covetrus Inc	2,941	N/A	168.9x
Amerisourcebergen Corp	36,150	21.3x	22.6x
Adapthealth Corp	1,217	14.4x	10.6x
Apria Inc	1,337	20.6x	21.6x
Cardinal Health Inc	37,262	23.9x	9.7x
Henry Schein Inc	8,827	21.7x	16.9x
Mckesson Corp	90,761	27.5x	24.7x
Patterson Companies Inc	2,772	20x	15.1x
PetIQ Inc	926	70x	55.9x

Industry median		21.3x	21.6x
(*) Profit after tax		-13	17
Equity value		-277	376

(/) Outstanding shares		140	140
Fair price		-2	3

CVET Relative Valuation

CVET Relative Valuation - Benchmarking P/E against peers

CVET Relative Valuation - Historical P/E Data